Skip to content
Research Article Open access CC BY 4.0

Effects of Highly Active Antiretroviral Treatment on Complete Blood Count Parameters

Simon Bannison Bani, Kwabena O. Danquah, Christian Obirikorang, William K. B. A. Owiredu, Lawrence Quaye, Samuel A. Sakyi, Yussif Adams, Peter Paul M. Dapare, Moses Banyeh, Barnabas B. N. Gandau

International STD Research & Reviews · pp. 1–12 · Published 6 Nov 2019

10.9734/ISRR/2019/v8i230100

Abstract

Aim: This study assesses the effects of HAART on complete blood count parameters among HIV infected participants. Study Design: Case control study. Place and Methods: This study was conducted in Tamale, Ghana from August, 2016 to December, 2017. Methodology: A total of 300 HIV infected participants with ages ranging from 19–79 years, administered with HAART for at least 6 months were recruited. Pre-HAART administration (baseline) demographic and clinical information, with initial full blood count results were retrieved from the medical records of the participants. Post HAART administration blood sample (5mLs) was taken from each participant into an EDTA vacutainer tube and complete blood count (CBC) performed using URIT 5250 haematology analyser. Participants transfused with blood over the last 4 months were excluded from the study. Results: The study recorded significant decreases in WBC and Neutrophil (%) post HAART administration. Lymphocyte (%), Haemoglobin, Haematocrit, MCV, MCHC, RDW-SD were all significantly higher post HAART administration. Total Platelets count, MPV, PDW-SD, PCT and P-LCR were significantly lower post-HAART administration. A comparison of the effects of EFV and NVP administered with AZT/3TC backbone yielded the following results. The NVP group recorded a significantly higher HCT compared with the EFV group (p-0.0073). A significantly higher mean PCT, MPV, P-LCR, PLCC, PDW-SD were recorded in the EFV group compared to the NVP group respectively. Conclusion: The administration of HAART is associated with significant improvements in erythroid and lymphoid lineages, reduce anaemia, improves immunity and general patient well-being. NVP improve erythroid cell indices while EFV ameliorate platelet indices. HAART regimen should be chosen based on the pre-HAART laboratory tests conducted on the individual.

Highly active antiretroviral therapy HIV infection haematological abnormalities.

References (18)

  1. 1 Microbial translocation is a cause of systemic immune activation in chronic HIV infection [DOI]
  2. 2 Viral dynamics in human immunodeficiency virus type 1 infection [DOI]
  3. 3 Epidemiology of Anemia in Human Immunodeficiency Virus (HIV)-Infected Persons: Results From the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project [DOI]
  4. 4 Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study [DOI]
  5. 5 HIV-associated anemia in children: a systematic review from a global perspective [DOI]
  6. 6 HAART-related nephropathies in HIV-infected patients [DOI]
  7. 7 Impact on Weight and Height With the Use of HAART in HIV-Infected Children [DOI]
  8. 8 Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study [DOI]
  9. 9 HIV-1 Drug-Resistance Surveillance among Treatment-Experienced and -Naïve Patients after the Implementation of Antiretroviral Therapy in Ghana [DOI]
  10. 10 T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host [DOI]
  11. 11 Initial Observations on the Efficacy of Highly Active Antiretroviral Therapy in the Treatment of HIV-Associated Autoimmune Thrombocytopenia [DOI]
  12. 12 Adult Combination Antiretroviral Therapy in Sub-Saharan Africa: Lessons from Botswana and Future Challenges [DOI]
  13. 13 Hematological Changes in HIV Patients Placed on Anti Retroviral Therapy in Markurdi, Benue State of Nigeria [DOI]
  14. 14 Effects of zidovudine on hemostatic and hematologic parameters in adult rats [DOI]
  15. 15 A stage structured model for HIV/AIDS in the presence of vertical transmission: The case of Ghana [DOI]
  16. 16 Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS [DOI]
  17. 17 Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
  18. 18 A Pre-HAART Follow-up Study of the Hematologic Manifestations in Children With Perinatal HIV-1 Infection: Suggestions for Reclassification of Clinical Staging [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

38

Page views

0

PDF downloads

8

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.